🕒 Friday 21 November 2025 Fri, 21 Nov 2025

Red Mountain Mining has significantly enlarged its Yellow Pine Antimony Project in Idaho by acquiring additional claims, increasing the project footprint by 75%. Positioned near major gold-antimony deposits, this move strengthens its foothold in a critical US mining district.

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

WA1 Resources has secured Major Project Status for its Luni Niobium Project, marking it as a critical national asset with government-backed facilitation for three years.

Diablo Resources has initiated maiden drilling at its Fair Dinkum copper prospect in Utah, capitalizing on the U.S. government's recent elevation of copper to critical mineral status and increased federal support for domestic supply chains.

Lindian Resources has begun construction of the Tipume accommodation village at its Kangankunde Rare Earths Project in Malawi, marking a critical step towards operational readiness. The modern camp is designed to support up to 90 personnel and is expected to be completed by early 2026.

Revolver Resources has upgraded its Dianne Copper Deposit resource with a 140% increase in Indicated material and a 26% rise in copper grade, setting the stage for a targeted mining restart in 2026.

ECS Botanics has achieved a milestone with direct-to-consumer sales exceeding 60% of total revenue, driven by the launch of innovative sugar-free THC gummies and a strategic distribution partnership.

Nationwide Building Society reports a solid first half of 2025 with underlying profit before tax rising to £977 million, driven by strong mortgage and deposit growth following its acquisition of Virgin Money. The Group maintains robust capital and credit quality while delivering significant value to members.

Golden State Mining has completed a $1.5 million placement at 0.8 cents per share, appointed Keith Middleton as Managing Director, and launched a strategic review of its gold projects in Western Australia.

Oceania Healthcare Limited reported a robust 1HY26 performance, marked by increased sales volumes, improved care profitability, and disciplined capital management. The company’s strategic focus on sales, operational excellence, and debt reduction sets a solid foundation for sustainable growth.

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Oceania Healthcare has posted a strong half-year turnaround with improved sales, cost savings, and reduced gearing, setting the stage for renewed growth and operational strength.

Oceania Healthcare reported a slight dip in revenue but impressive gains in profitability for the first half of 2025, highlighting operational resilience amid a challenging environment.

EROAD Limited reported a 3.3% revenue increase and strong free cash flow in H1 FY26, driven by ANZ market expansion despite a significant North American impairment. The company is focusing on the promising electronic Road User Charges opportunity in Australasia.